Wednesday, 16 August 2017

Japan News

  • Japan approves Bayer's EYLEA Injection

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2015

    Regeneron Pharmaceuticals Inc. has announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin Ltd, has received approval for EYLEA (aflibercept) Injection by the Ministry of Healt...Read more

  • Japanese patent for Imugene drug delivery tech

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013

    Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug delivery technology Linguet. Japanese application provides protection aroun...Read more

  • Daiichi Sankyo's subsidiary launches four new generic drugs

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, will launch seven new generic drugs with four new active ingredients. T...Read more

  • Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016

    Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

  • Sysmex gets FDA nod for XN hematology analyzers

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 24 Oct, 2012

    Singapore: Sysmex America, and Sysmex, Kobe, Japan, announced that the US FDA has cleared the Sysmex XN-Series Hematology Analyzers. Sysmex previously received a Medical Device License for...Read more

  • Netzsch acquires Bruker's thermal analyzer business in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012

    Singapore: Netzsch Japan KK acquired Bruker Corporation's thermal analysis instruments business in Japan. Netzsch Japan will further develop, produce, distribute and service the existing an...Read more

  • Boston Scientific completes enrollment in SuperNOVA trial

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2013

    Singapore: Boston Scientific has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and effectiven...Read more

  • mHealth apps market to reach $20.7 bn by 2018: Report

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2013

    Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in 2013 and will grow to $20.7 billion by 2018 at a CAGR of 25.50 percen...Read more

  • CSL Behring seeks Japan PMDA approval for Hemophilia drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015

    Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its investigational fusion protein l...Read more

  • BBK Worldwide opens Tokyo office; appoints new Managing Director

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Japan. Mori will lead business development and help drive sales and mar...Read more

  • Gore's new endovascular therapy set to go for trials in Japan and US

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    W. L. Gore & Associates, Inc. (Gore) has announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE EXCLUDER Conformabl...Read more

  • Baylor Miraca Genetics appoints Gary Huff as President, CEO

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Baylor Miraca Genetics Laboratories LLC (BMGL), a joint venture company between Japan-based Miraca Holdings and Baylor College of Medicine, announced that Gary Huff will join the company as...Read more

  • Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst

    Japan |  Analysis | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

    Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, representing a moderate compound annual growth rate (CAGR) of 4.6 pe...Read more

  • Teijin, Pulmagen enter agreement for asthma drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012

    Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeutics, a UK-based drug development company, have signed an exclusive l...Read more

  • Australian Cellmid acquires Japanese Advangen

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 09 May, 2013

    Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product range, which was orig...Read more

  • Belgium 3D printing firm forays into Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

    Materialise NV, a Belgium-based provider of 3D software and sophisticated 3D printing solutions, and a pioneer in medical image-based guided technology, has signed a 5-year partnership agre...Read more

  • Japan's Mitsubishi Tanabe pharma to revamp operations

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

    Singapore: With a view to streamline operations and speed up new drug launches, Japan's Mitsubishi Tanabe pharma recently announced plans to revamp and reorganize its three drug development...Read more

  • NTT's conductive fiber to help in biomedical recordings

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013

    Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating the surface of silk or synthetic fiber with conductive polymer (PEDO...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls